---
title: "AccuStem Sciences, Inc. (ACUT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ACUT.US.md"
symbol: "ACUT.US"
name: "AccuStem Sciences, Inc."
industry: "Biotechnology"
---

# AccuStem Sciences, Inc. (ACUT.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [accustem.com](https://accustem.com) |

## Company Profile

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography scree...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.68 | 370/603 | - | - | - |
| PB | -2.60 | 498/603 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/ACUT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ACUT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ACUT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.